Silk Road Medical Inc - Company Profile
Powered by
All the data and insights you need on Silk Road Medical Inc in one report.
- Save hours of research time and resources with
our up-to-date Silk Road Medical Inc Strategy Report
- Understand Silk Road Medical Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Silk Road Medical Inc (Silk Road) develops and manufactures medical devices for the treatment of carotid artery diseases. The company’s product portfolio includes the ENROUTE trans carotid neuroprotection system, ENROUTE trans carotid stent system, ENHANCE trans carotid peripheral access kit and ENROUTE 0.014” guidewire. Silk Road focuses to develop therapies for carotid artery disease called trans carotid artery revascularization (TCAR). Its TCAR approach combines surgical principles of neuroprotection with invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The company offers products under the brand names Enroute and Enhance. Silk Road is headquartered in Sunnyvale, California, the US.
Silk Road Medical Inc premium industry data and analytics
Products and Services
Products | Brands |
---|---|
ENROUTE Transcarotid Neuroprotection System | Enroute |
ENHANCE Transcarotid Peripheral Access Kit | Enhance |
ENROUTE Transcarotid Stent System | TCAR |
XYZ | |
XYZ | |
XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | New Products/Services | In March, the company introduced its Tapered ENROUTE Transcarotid Stent System to hospitals in the US. |
2022 | Official Trials/Tests | In September, the company announced enrollment of the first patient in ROADSTER 3, the first prospective, multi-center, single-arm study to assess real-world treatment of standard surgical risk (SSR) patients with carotid artery disease using TCAR. |
2022 | Others | In June, the company announced a prospective study to evaluate the TCAR system in the treatment of standard surgical risk patients with carotid artery disease. |
Competitor Comparison
Key Parameters | Silk Road Medical Inc | Stryker Corp | Inspire Medical Systems Inc | SI-Bone Inc | Bolton Medical Inc |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
City | Sunnyvale | Kalamazoo | Golden Valley | Santa Clara | Sunrise |
State/Province | California | Michigan | Minnesota | California | Florida |
No. of Employees | 414 | 52,000 | 1,011 | 357 | - |
Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Jack W. Lasersohn | Chairman | Executive Board | 2021 | 69 |
Chas McKhann | Chief Executive Officer | Senior Management | 2023 | - |
Lucas W. Buchanan | Chief Operating Officer; Chief Financial Officer | Senior Management | 2020 | 45 |
Kevin M. Klemz | Chief Legal Officer; Secretary; Executive Vice President | Senior Management | 2022 | 61 |
Sumaira Macdonald | Executive Medical Director | Senior Management | - | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward